Somatic Missense Mutations of Histone Variant H3.3 in Central Nervous System Cancers

Basit Öğe Kaydı
dc.contributor.authorSut, Burcu Biterge
dc.date.accessioned2024-11-07T10:40:17Z
dc.date.available2024-11-07T10:40:17Z
dc.date.issued2020
dc.departmentNiğde Ömer Halisdemir Üniversitesi
dc.description.abstractObjective: Histone variants are important modulators of chromatin functions. Studies have pointed out that epigenetic factors are often dysregulated in carcinogenesis. Although some cancer-Associated mutations of the histone variant H3.3 have been identified previously, a complete list of H3.3 mutations and their potential effects is yet to be uncovered. Therefore, this study aims to identify the missense mutations of the histone variant H3.3 in central nervous system (CNS) cancers and to computationally predict their functional consequences on pathogenicity, protein stability and structure. Materials and Methods: A complete set of human H3.3 mutations was acquired from the COSMIC v90 database and missense mutations were selected. The potential effects of these mutations were assessed using PredictSNP2 and FATHMMXF. Structural outcomes were predicted using MUpro and HOPE servers. Results: We identified 45 unique missense H3.3 substitutions in several tissues including CNS. PredictSNP2 and FATHMM-XF predicted 17 and 42 mutations as deleterious respectively, most of which caused decreased protein stability. Amino acid alterations in CNS cancers were predicted to cause alterations of the 3D structure. Conclusion: Histone variants play significant roles in epigenetic regulation and are often mutated in cancers. Our results showed that H3.3 mutations detected in CNS cancers could affect the genomic distribution of post-Translational modifications and histone variants, hence dramatically alter the gene expression profile and contribute to carcinogenesis. © Istanbul University Press. All rights reserved.
dc.identifier.doi10.26650/EurJBiol.2020.0019
dc.identifier.endpage82
dc.identifier.issn2602-2575
dc.identifier.issue2
dc.identifier.scopus2-s2.0-85150663390
dc.identifier.scopusqualityQ4
dc.identifier.startpage75
dc.identifier.trdizinid461982
dc.identifier.urihttps://doi.org/10.26650/EurJBiol.2020.0019
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/461982
dc.identifier.urihttps://hdl.handle.net/11480/11538
dc.identifier.volume79
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherIstanbul University Press
dc.relation.ispartofEuropean Journal of Biology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241106
dc.subjectCancer
dc.subjectEpigenetics
dc.subjectHistone variant H3.3
dc.subjectMutation analysis
dc.titleSomatic Missense Mutations of Histone Variant H3.3 in Central Nervous System Cancers
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu